Annual Accounts Payable
$8.43 M
+$2.41 M+39.93%
December 1, 2023
Summary
- As of February 7, 2025, ZVSA annual accounts payable is $8.43 million, with the most recent change of +$2.41 million (+39.93%) on December 1, 2023.
- During the last 3 years, ZVSA annual accounts payable has risen by +$6.12 million (+264.69%).
- ZVSA annual accounts payable is now at all-time high.
Performance
ZVSA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$9.28 M
+$968.10 K+11.64%
September 1, 2024
Summary
- As of February 7, 2025, ZVSA quarterly accounts payable is $9.28 million, with the most recent change of +$968.10 thousand (+11.64%) on September 1, 2024.
- Over the past year, ZVSA quarterly accounts payable has increased by +$1.16 million (+14.23%).
- ZVSA quarterly accounts payable is now at all-time high.
Performance
ZVSA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ZVSA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +39.9% | +14.2% |
| 3 y3 years | +264.7% | +120.8% |
| 5 y5 years | +264.7% | +120.8% |
ZVSA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +321.6% | at high | +364.2% |
| 5 y | 5-year | at high | +321.6% | at high | +364.2% |
| alltime | all time | at high | +321.6% | at high | +364.2% |
ZyVersa Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.28 M(+11.6%) |
| Jun 2024 | - | $8.32 M(+2.3%) |
| Mar 2024 | - | $8.13 M(-3.6%) |
| Dec 2023 | $8.43 M | $8.43 M(-5.2%) |
| Sep 2023 | - | $8.90 M(+9.3%) |
| Jun 2023 | - | $8.14 M(+27.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $6.38 M(+5.9%) |
| Dec 2022 | $6.03 M(+201.3%) | $6.03 M(-7.4%) |
| Sep 2022 | - | $6.50 M(+54.7%) |
| Jun 2022 | - | $4.20 M(+110.2%) |
| Dec 2021 | $2.00 M(-13.5%) | - |
| Dec 2021 | - | $2.00 M |
| Dec 2020 | $2.31 M | - |
FAQ
- What is ZyVersa Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics annual accounts payable year-on-year change?
- What is ZyVersa Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics quarterly accounts payable year-on-year change?
What is ZyVersa Therapeutics annual accounts payable?
The current annual accounts payable of ZVSA is $8.43 M
What is the all time high annual accounts payable for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high annual accounts payable is $8.43 M
What is ZyVersa Therapeutics annual accounts payable year-on-year change?
Over the past year, ZVSA annual accounts payable has changed by +$2.41 M (+39.93%)
What is ZyVersa Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ZVSA is $9.28 M
What is the all time high quarterly accounts payable for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high quarterly accounts payable is $9.28 M
What is ZyVersa Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ZVSA quarterly accounts payable has changed by +$1.16 M (+14.23%)